Search Within

Tiffany A Traina

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (49)
  2. Journal Article (34)
  3. Guidelines (1)
  4. Review (1)
Groups
  1. Biostatistics Service (85)
  2. Breast Medicine Service (85)
  3. Department of Medicine (85)
  4. Epidemiology and Biostatistics (85)
  5. Solid Tumor Oncology Division (85)
  6. Survivorship Research (85)

More Groups

People
  1. Sujata Patil (62)
  2. Clifford Hudis (47)
  3. Larry Norton (33)
  4. Ayca Gucalp (24)
  5. Chau Dang (20)
  6. Mark Robson (20)

More People

Years
  1. 2024 (5)
  2. 2023 (3)
  3. 2022 (5)
  4. 2021 (4)
  5. 2020 (4)
  6. 2019 (2)

More Years

Publications
  1. Journal of Clinical Oncology (25)
  2. Cancer Research (15)
  3. Breast Cancer Research and Treatment (7)
  4. Clinical Cancer Research (4)
  5. International Journal of Radiation Oncology, Biology, Physics (4)
  6. Annals of Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (25)
  2. American Association for Cancer Research (19)
  3. Springer (13)
  4. Elsevier Inc. (10)
  5. Oxford University Press (4)
  6. John Wiley & Sons (3)

More Publishers

Results (85)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Androgen receptor inhibition can stabilize disease in patients with AR(+), ER(-)/PR(-) metastatic breast cancer
    Meeting Abstract

    Traina, T. A.; Feigin, K.; Patil, S.; Yuan, J.; Dickler, M.; Andrea, G. D.; Bromberg, J.; Hudis, C.
    Annals of Oncology (2009)

    Fulltext@MSK | Save
  • PIK3CA and AKT1 mutations are independent in invasive breast cancer
    Meeting Abstract

    Moynahan, M. E.; Heguy, A.; Drobnjak, M.; Traina, T.; Howard, J.; Patil, S.; Gerald, W.; Solit, D.; Hudis, C.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Cardiac safety of adjuvant bevacizumab (B) plus dose-dense doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-P) in patients with early stage breast cancer
    Meeting Abstract

    Mcarthur, H.; Rugo, H.; Nulsen, B.; Traina, T.; Patil, S.; Zhou, Q.; Steingart, R.; Dang, C.; Park, J.; Moasser, M.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodes
    Journal Article

    Karam, A. K.; Hsu, M.; Patil, S.; Stempel, M.; Traina, T. A.; Ho, A. Y.; Cody, H. S.; Port, E. R.; Morrow, M.; Gemignani, M. L.
    Annals of Surgical Oncology (2009)

    Fulltext@MSK | Save
  • PIK3CA mutation associates with improved outcome in breast cancer
    Journal Article

    Kalinsky, K.; Jacks, L.; Heguy, A.; Patil, S.; Drobnjak, M.; Bhanot, U. K.; Hedvat, C. V.; Traina, T. A.; Solit, D.; Gerald, W.; more...
    Clinical Cancer Research (2009)

    Fulltext@MSK | Save
  • A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Patil, S.; Edwards, C.; Norton, L.; Hudis, C. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer
    Journal Article

    Traina, T. A.; Theodoulou, M.; Feigin, K.; Patil, S.; Tan, L. K.; Edwards, C.; Dugan, U.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer
    Journal Article

    Traina, T. A.; Poggesi, I.; Robson, M.; Asnis, A.; Duncan, B. A.; Heerdt, A.; Dang, C.; Lake, D.; Moasser, M.; Panageas, K.; more...
    Breast Cancer Research and Treatment (2008)

    Fulltext@MSK | Save
  • Phase I study of a novel capecitabine schedule based on Norton-Simon mathematical modeling
    Meeting Abstract

    Theodoulou, M.; Traina, T. A.; Dugan, U.; Lake, D.; Fornier, M.; Feigin, K.; Patil, S.; Edwards, C.; Norton, L.; Hudis, C. A.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Adjuvant (adj) bevacizumab (B) plus dose-dense (dd) doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-p) in early stage breast cancer (BC) patients (pts): Cardiac safety
    Meeting Abstract

    Dickler, M. N.; Traina, T.; Panageas, K.; Steingart, R.; Dang, C.; Fornier, M.; Sugarman, S.; Norton, L.; Hudis, C.; Rugo, H.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save